SCHEMBL12818290

SCHEMBL12818290

N#Cc1ccc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc4c(c2)CCC4)CC[S+]3[O-])cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 3/20 0.47
▸ CYP11B2 P19099 2/20 0.47
▸ HTR2C P28335 3/20 0.42
▸ HTR6 P50406 2/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ NR3C1 P04150 1/20 0.39
▸ AR P10275 1/20 0.39
▸ KDM2B Q8NHM5 3/20 0.38
▸ MCL1 Q07820 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HTR2B P41595 2/20 0.36
▸ TNF P01375 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ NOD1 Q9Y239 1/20 0.36
▸ MLNR O43193 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818556 0.98 CYP11B1 (0.47) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL12818566 0.85 CYP11B1 (0.35) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL12818649 0.83 CYP11B1 (0.43) CYP11B1CYP11B2HTR2CHTR6HTR2A
SCHEMBL12818905 0.83 CYP11B1 (0.35) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL1817915 0.81 CCR6 (0.45) CYP11B1CYP11B2
SCHEMBL12818247 0.81 GAA (0.42) CYP11B1CYP11B2KDM2BGAA
SCHEMBL12818419 0.79 HTR6 (0.40) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL12818513 0.79 CYP11B1 (0.48) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL12818035 0.78 CYP11B1 (0.47) CYP11B1CYP11B2HTR2CHTR6DRD2
SCHEMBL12817726 0.78 HSPD1 (0.38) CYP11B1CYP11B2KDM2BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback